In the study, conducted at the Spanish National Cancer Research Center (CNIO), researchers conducted experiments on mice to treat pancreatic cancer, one of the cancers with the lowest survival rate.
Researchers have found that pancreatic tumors in mice can be destroyed using “triple combination therapy.”
The researchers noted that this study paves the way for the development of new combination treatments that can increase the survival rate of patients with “pancreatic ductal adenocarcinoma,” and stated that the study also provides direction for the development of new clinical trials.
The researchers pointed out that the mice on which the experiment was carried out did not show resistance to the drugs administered.
On the other hand, clinical studies must be carried out to determine the effects of the study on humans.
Mariano Barbacid, head of the CNIO Experimental Oncology Group, emphasized in his statement that they are not yet at the stage of conducting clinical trials with this triple therapy.
“Triple combination therapy” means that three different drugs are administered at the same time to suppress the cancer cell through three different mechanisms at the same time.
The research results were published in the journal Proceedings of the National Academy of Sciences (PNAS).
Bir yanıt yazın